Expert Opinion on Drug Discovery, Volume 14, Issue 10 (2019)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Discovery, Volume 14, Issue 10 (2019)

See all volumes and issues
Vol 19, 2024 Vol 18, 2023 Vol 17, 2022 Vol 16, 2021 Vol 15, 2020 Volume 14, 2019 Vol 13, 2018 Vol 12, 2017 Vol 11, 2016 Vol 10, 2015 Vol 9, 2014 Vol 8, 2013 Vol 7, 2012 Vol 6, 2011 Vol 5, 2010 Vol 4, 2009 Vol 3, 2008 Vol 2, 2007 Vol 1, 2006
Download citations Download PDFs Download issue

Editorial

Editorial
How do we choose the appropriate animal model for antiseizure therapy development?
Melissa Barker-Haliski
Pages: 947-951
Published online: 28 Jun 2019
AbstractforHow do we choose the appropriate animal model for antiseizure therapy development? | Full Text | References | PDF (615.6 KB) | EPUB
  • 1983 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Can 4D bioprinting revolutionize drug development?
Izeia Lukin, Saioa Musquiz, Itsasne Erezuma, Taleb H. Al-Tel, Nasim Golafshan, Alireza Dolatshahi-Pirouz & Gorka Orive
Pages: 953-956
Published online: 08 Jul 2019
First Page PreviewforCan 4D bioprinting revolutionize drug development? | Full Text | References | PDF (528.4 KB) | EPUB
  • 4270 Views
  • 22 CrossRef citations
  • 0Altmetric
Free Access

Perspective

Article
Challenges to drug discovery for celiac disease and approaches to overcome them
Luis Vaquero, David Bernardo, Francisco León, Laura Rodríguez-Martín, Begoña Alvarez-Cuenllas & Santiago Vivas
Pages: 957-968
Published online: 16 Jul 2019
AbstractforChallenges to drug discovery for celiac disease and approaches to overcome them | Full Text | References | PDF (917.3 KB) | EPUB
  • 205 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Animal models of synucleinopathies and how they could impact future drug discovery and delivery efforts
Kurt A. Jellinger
Pages: 969-982
Published online: 05 Jul 2019
AbstractforAnimal models of synucleinopathies and how they could impact future drug discovery and delivery efforts | Full Text | References | PDF (1 MB) | EPUB
  • 232 Views
  • 4 CrossRef citations
  • 0Altmetric

Review

Review
Novel screening approaches for human prion diseases drug discovery
Fabio Moda, Maria Laura Bolognesi & Giuseppe Legname
Pages: 983-993
Published online: 04 Jul 2019
AbstractforNovel screening approaches for human prion diseases drug discovery | Full Text | References | PDF (1.2 MB) | EPUB
  • 236 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?
Paolo Guglielmi, Simone Carradori, Alessandra Ammazzalorso & Daniela Secci
Pages: 995-1035
Published online: 03 Jul 2019
AbstractforNovel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement? | Full Text | References | PDF (7.7 MB) | EPUB
  • 178 Views
  • 40 CrossRef citations
  • 0Altmetric
Review
The human gut microbiome – a new and exciting avenue in cardiovascular drug discovery
Yu Du, Xingxing Li, Chunyan Su, Li Wang, Jiandong Jiang & Bin Hong
Pages: 1037-1052
Published online: 18 Jul 2019
AbstractforThe human gut microbiome – a new and exciting avenue in cardiovascular drug discovery | Full Text | References | PDF (1.4 MB) | EPUB
  • 577 Views
  • 8 CrossRef citations
  • 0Altmetric
Review
Design of α-helical antimicrobial peptides with a high selectivity index
Davor Juretić & Juraj Simunić
Pages: 1053-1063
Published online: 16 Jul 2019
AbstractforDesign of α-helical antimicrobial peptides with a high selectivity index | Full Text | References | PDF (1,011.7 KB) | EPUB
  • 359 Views
  • 21 CrossRef citations
  • 0Altmetric
Review
Recent advances in computational design of potent aromatase inhibitors: open-eye on endocrine-resistant breast cancers
Angelo Spinello, Ida Ritacco & Alessandra Magistrato
Pages: 1065-1076
Published online: 24 Jul 2019
AbstractforRecent advances in computational design of potent aromatase inhibitors: open-eye on endocrine-resistant breast cancers | Full Text | References | PDF (1.5 MB) | EPUB
  • 157 Views
  • 12 CrossRef citations
  • 0Altmetric
Review
Computational re-design of protein structures to improve solubility
Susanna Navarro & Salvador Ventura
Pages: 1077-1088
Published online: 08 Jul 2019
AbstractforComputational re-design of protein structures to improve solubility | Full Text | References | PDF (1.5 MB) | EPUB
  • 469 Views
  • 13 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Complementary strategies to be used in conjunction with animal models for multiple sclerosis drug discovery: adapting preclinical validation of drug candidates to the need of remyelinating strategies
Imane Charmarke-Askar et al.
Review Article | Published online: 22 Jul 2024
What impact does tautomerism have on drug discovery and development?
Devendra K. Dhaked et al.
Editorial | Published online: 16 Jul 2024
Free Access
Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery
Leticia Manen-Freixa et al.
Review Article | Published online: 14 Jul 2024
Inhibitors and PROTACs of CDK2: challenges and opportunities
Yangjie Zeng et al.
Review Article | Published online: 12 Jul 2024
View all latest articles